Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Italy Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20091
20101
20111
20121
20141
20151
20161
20172
20183
20191
20203
20212
20222
20231
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting6
Recruiting5
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
pharmaand GmbH4
Amgen3
Merck Sharp & Dohme LLC3
AbbVie2
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
ImmunoGen, Inc.2
Novartis Pharmaceuticals2
Advenchen Laboratories, LLC1
CanariaBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms32
Ovarian Neoplasms28
Carcinoma, Ovarian Epithelial17
Peritoneal Neoplasms7
Neoplasms3
Recurrence2
Endometrial Neoplasms1
Genital Neoplasms, Male1
Neoplasm Metastasis1
Pathologic Complete Response1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.